v3.26.3
LEASES
3 Months Ended
Aug. 31, 2026
Leases  
LEASES

NOTE 5: LEASES

 

We lease facilities in Irvine, California and Mexicali, Mexico.

 

As of August 31, 2026, we had approximately 22,000 square feet of floor space at our corporate headquarters at 17571 Von Karman Avenue in Irvine, California, which we have been leasing since 2009. This facility includes administration, research and development, certain manufacturing, shipping and inventory storage. In May 2026, we exercised the additional five-year extension option and entered into a lease extension agreement with the landlord, extending the lease for an additional five-year term commencing September 1, 2026, and expiring August 31, 2031. The monthly base rent at the commencement of the extended term is approximately $28,400 and is subject to scheduled increases during the lease term.

 

In November 2016, our Mexican subsidiary, Biomerica de Mexico, entered into a 10-year lease for approximately 8,100 square feet of manufacturing space located in Mexicali, Mexico. The lease includes an option to renew for an additional 10-year term. As of May 31, 2026, management determined that exercise of the renewal option was reasonably certain and, accordingly, the additional 10-year renewal period was included in the lease term used to measure the related right-of-use asset and lease liability. As of August 31, 2026, documentation formalizing the renewal had not yet been executed with the landlord. The current rent is approximately $4,300 per month. Biomerica de Mexico also leases a smaller unit on a month-to-month basis for use in one manufacturing process.

 

In addition, we lease a small office in Lindau, Germany on a month-to-month basis, which serves as the headquarters of BioEurope GmbH, our German subsidiary.

 

For purposes of determining straight-line rent expense, the lease term is calculated from the date we first take possession of the facility, including any periods of free rent and any renewal option periods that we are reasonably certain to exercise. Our office and equipment leases generally have contractually specified minimum rent, and annual rent increases are included in the measurement of the right-of-use asset and related lease liabilities. Additionally, under these lease arrangements, we may be required to pay directly, or reimburse the lessors, for certain maintenance and operating costs. Such amounts are generally variable and, therefore, not included in the measurement of the right-of-use asset and related lease liabilities but are instead recognized as variable lease expense in the condensed consolidated statements of operations and comprehensive loss when they are incurred.

 

 

The following table presents information on our operating leases for the three months ended August 31, 2026 and August 31, 2025:

 

   2026   2025 
   Three Months Ended August 31, 
   2026   2025 
Operating lease cost  $104,000   $88,000 
Variable lease cost   2,000    3,000 
Short-term lease cost   1,000    - 
Total lease cost  $107,000   $91,000 

 

The maturities of operating lease liabilities as of August 31, 2026 are as follows:

 

Year Ending May 31:

   

   Operating Leases 
2027 (excluding the three months ended August 31, 2026)  $392,000 
2028   406,000 
2029   420,000 
2030   434,000 
2031   450,000 
Thereafter   266,000 
Total minimum future lease payments   2,368,000 
Less: imputed interest   542,000 
Total operating lease liabilities  $1,826,000 

 

The following table summarizes our other supplemental lease information for the three months ended August 31, 2026 and August 31, 2025:

 

   2026   2025 
   Three Months Ended August 31, 
   2026   2025 
Cash paid for operating lease liabilities  $98,000   $92,000 
Weighted-average remaining lease term (years)   5.98    1.02 
Weighted-average discount rate   9.00%   5.78%

 

We also have various insignificant leases for office equipment.